biphasic human insulin
Sponsors
Novo Nordisk A/S
Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Phase 2
Phase 3
Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.
CompletedNCT00476437
Start: 2007-04-30End: 2007-11-30Updated: 2023-11-02
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes
CompletedNCT00617565
Start: 2003-07-08End: 2003-11-26Updated: 2017-02-24
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes
CompletedNCT01467323
Start: 1998-04-30End: 1998-09-30Updated: 2017-01-04
Phase 4
Unknown Phase
Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents
CompletedNCT00715780
Start: 2008-06-30End: 2009-07-31Updated: 2016-11-07
NovoLet® Surveillance Study on Using Human Insulin System in Indonesia
CompletedNCT01492153
Start: 2003-02-11End: 2006-09-05Updated: 2017-02-28